At the end of the latest market close, Talis Biomedical Corporation (TLIS) was valued at $10.10. In that particular session, Stock kicked-off at the price of $10.10 while reaching the peak value of $12.7099 and lowest value recorded on the day was $9.85. The stock current value is $12.12.
Recently in News on May 11, 2021, Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress. Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Talis Biomedical Corporation shares are logging -64.25% during the 52-week period from high price, and 28.53% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $9.43 and $33.90.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2686718 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Talis Biomedical Corporation (TLIS) recorded performance in the market was -56.40%, having the revenues showcasing -0.41% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 313.30M, as it employees total of 133 workers.
The Analysts eye on Talis Biomedical Corporation (TLIS)
During the last month, 0 analysts gave the Talis Biomedical Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 11.98, with a change in the price was noted -4.73. In a similar fashion, Talis Biomedical Corporation posted a movement of -28.07% for the period of last 100 days, recording 262,557 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TLIS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Talis Biomedical Corporation (TLIS)
Raw Stochastic average of Talis Biomedical Corporation in the period of last 50 days is set at 82.01%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 81.67%. In the last 20 days, the company’s Stochastic %K was 41.72% and its Stochastic %D was recorded 26.46%.
Considering, the past performance of Talis Biomedical Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -56.40%. The shares increased approximately by 20.84% in the 7-day charts and went down by 23.93% in the period of the last 30 days. Common stock shares were lifted by -0.41% during last recorded quarter.